LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading On TSX Venture Exchange
LevelJump Healthcare (TSXV: JUMP) has announced that the Ontario Securities Commission (OSC) has revoked its Failure-to-File Cease Trade Order (FFCTO) that was issued on May 7, 2025. The company has now met all continuous disclosure obligations under securities legislation and is actively seeking reinstatement of trading on the TSX Venture Exchange.
The company will issue a news release before trading resumes.
LevelJump Healthcare (TSXV: JUMP) ha annunciato che la Ontario Securities Commission (OSC) ha revocato l'Ordine di Cessazione del Commercio per Mancata Presentazione (FFCTO) emesso il 7 maggio 2025. La società ha ora adempiuto a tutti gli obblighi di comunicazione continua previsti dalla normativa sui titoli e sta attivamente cercando il ripristino della negoziazione sul TSX Venture Exchange.
La società rilascerà un comunicato stampa prima della ripresa delle negoziazioni.
LevelJump Healthcare (TSXV: JUMP) ha anunciado que la Comisión de Valores de Ontario (OSC) ha revocado la Orden de Cese de Comercio por Incumplimiento de Presentación (FFCTO) emitida el 7 de mayo de 2025. La empresa ha cumplido con todas las obligaciones de divulgación continua bajo la legislación de valores y está buscando activamente la reinstauración de la negociación en la Bolsa de Valores de TSX Venture.
La empresa emitirá un comunicado de prensa antes de que se reanuden las operaciones.
LevelJump Healthcare (TSXV: JUMP)는 온타리오 증권위원회(OSC)가 2025년 5월 7일에 발령한 미제출 거래중지 명령(FFCTO)을 철회했다고 발표했습니다. 회사는 현재 증권법에 따른 모든 지속적 공시 의무를 충족했으며, TSX 벤처 거래소에서의 거래 재개를 적극적으로 추진하고 있습니다.
거래가 재개되기 전에 회사는 보도자료를 발행할 예정입니다.
LevelJump Healthcare (TSXV : JUMP) a annoncé que la Commission des valeurs mobilières de l’Ontario (OSC) a levé son Ordre de cessation de négociation pour non-dépôt (FFCTO) émis le 7 mai 2025. La société a désormais rempli toutes les obligations de divulgation continue prévues par la législation sur les valeurs mobilières et cherche activement à rétablir la négociation à la Bourse de croissance TSX.
La société publiera un communiqué de presse avant la reprise des échanges.
LevelJump Healthcare (TSXV: JUMP) hat bekannt gegeben, dass die Ontario Securities Commission (OSC) ihre am 7. Mai 2025 erlassene Anordnung zum Handelsverbot wegen Nicht-Einreichung (FFCTO) aufgehoben hat. Das Unternehmen hat nun alle kontinuierlichen Offenlegungspflichten gemäß den Wertpapiergesetzen erfüllt und bemüht sich aktiv um die Wiederaufnahme des Handels an der TSX Venture Exchange.
Das Unternehmen wird eine Pressemitteilung herausgeben, bevor der Handel wieder aufgenommen wird.
- Revocation of Cease Trade Order by OSC
- Company is now current on continuous disclosure obligations
- Actively pursuing trading reinstatement on TSX Venture Exchange
- Company faced trading suspension for over a month due to failure to file required documents
Toronto, Ontario--(Newsfile Corp. - June 24, 2025) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its news release of June 23, 2025, the Ontario Securities Commission (the "OSC") has revoked a Failure-to-File Cease Trade Order (the "FFCTO") that had been originally issued by the OSC against the Company on May 7, 2025. The Company is now current on its continuous disclosure obligations under securities legislation.
As also previously announced, the Company is in the process of applying to the TSX Venture Exchange for reinstatement of trading in its common shares. A news release will be issued prior to the resumption of trading.
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/256654